FDA panel evaluates MDMA therapy for post-traumatic stress disorder
What is the framework for approval? In 2017, the FDA granted “breakthrough” status to MDMA-assisted therapy. Status, the recognition of a drug's therapeutic promise, aims to shorten regulatory times. The…